[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]


In the cancer wars Tamoxifen has proven catastrophic. 
Except, of course, for the obscene amounts of money
made by Imperial Chemical Industries(ICI) for this
CARCINOGEN, which CURES?? cancer.  Phytoestrogens from
soy products, etc. seem a better choice.  Read "What
Your Doctor May NOT Tell You About Menopause" By
Doctor John Lee about the benefits of NATURAL

--- Lillian <> wrote:
> Jo Anne;  Welcome to our wonderful forum, I am a
> five year breast cancer
> survivor and was on the drug Tamoxifen for
> approximately six months.  Please
> know we are pleased you are doing so well as a
> breast cancer survivor; but
> concerned about your side effects to tamoxifen. 
> There are two other drugs
> that work equally as well as tamoxifen; with few
> side effects; however most
> drugs have some sort of side effect or another.  The
> secret is to use the
> drug with the less serious of side effects and
> fewer.  The drugs are :
> Megrace and Arimidex.
> I am including information of side effects that some
> of us on the forum have
> been working on.  Hope this is of help to you.  Stay
> and chat with us,
> warmly, your friend, lillian
> (Excerpt From Cancer & Hormone Paper)
> Tamoxifen has been formally declared by the World
> Health Organization as a
> carcinogen.  Under State Proposition 65, California
> must publish and
> maintain a list of all known carcinogens.  In 1995,
> the state's Carcinogen
> Identification Committee voted unanimously to list
> tamoxifen.  Tamoxifen's
> known side effects include:
> Liver Damage :    Britain withdrew from studies on
> the use of tamoxifen when
> it was discovered that tamoxifen's manufacturer
> withheld unpublished data
> indicating that the drug may induce liver tumors.
> Liver damage has occurred
> in every animal study using tamoxifen.  Animal
> studies show tamoxifen
> produces potentially carcinogenic DNA and
> alterations in the liver, as well
> as eye damage.
> Uterine Cancer :    Although the drug has had some
> success in preventing
> recurrences in women who have been successfully
> treated for breast cancer,
> it does promote particularly aggressive uterine
> cancer. A large Swedish
> study, and another in the Netherlands, found a
> 6-fold increase in uterine
> cancer among those patients who took tamoxifen.  In
> a University of
> Pittsburgh study, 23 out of 1,000 given the drug,
> contracted uterine cancer.
> Endometrial Effects :   A Danish/British study
> detected endometrial
> abnormalities.  Uterine tumors, endometrial
> thickenings, and cancers
> occurred in a significant number of women taking
> tamoxifen.
> Blood Clots :   It is also known to cause fatal
> blood clots in the lungs,
> irritating the walls of the veins, and leading to
> inflammation.
> Osteoporosis :   Taxmoxifen users are at risk of
> developing early symptoms
> of menopause, including accelerated bone mineral
> loss and osteoporosis.
> Other adverse reactions which are seen infrequently
> are hypercalcemia,
> peripheral edema, distaste for food, pruritus vulvae
> (vaginal itching),
> depression, dizziness, light-headedness, headache,
> hair thinning and/or
> partial hair loss, and vaginal dryness.
> NOLVADEX has been associated with changes in liver
> enzyme levels, and on
> rare occasions, a spectrum of more severe liver
> abnormalities including
> fatty liver, cholestasis, hepatitis and hepatic
> necrosis.
> Tamoxifen: A Major Medical Mistake?
>                              by Sherrill Sellman
>        Extracted from Nexus Magazine, Volume 5, #4
> (June - July 1998)
>      Once praised for its benefits in preventing
> breast cancer
>      recurrence, the lucrative pharmaceutical drug
> tamoxifen is now
>      implicated in causing dangerous side-effects,
> including other
>      types of cancers.
>      In the early 1970's, a shameful chapter closed
> on the widespread
>      use of a known carcinogenic and
> endocrine-disrupting drug called
>      DES (diethylstilboestrol), the first synthetic,
> non-steroidal
>      estrogen drug. Against the advice of its
> creator, Sir Charles
>      Dodd, between four and six million American and
> European women and
>      10,000 Australian women innocently used DES for
> the prevention of
>      miscarriage and pregnancy complications.
>      In addition, DES became a popular though
> unproven drug for a
>      variety of other conditions. It was used for
> the suppression of
>      lactation, the treatment of acne, the treatment
> of certain types
>      of breast and prostatic cancer, and as an
> inhibitor of growth in
>      young girls, an estrogen replacement in
> menopause and a "morning
>      after" pill.
>      It would take 30 years to accept what
> laboratory tests had
>      indicated as early as 1938 - that DES was a
> highly dangerous and
>      harmful drug. It was reported that, 20 years
> after taking DES,
>      mothers had a 40 to 50 per cent greater risk of
> breast cancer than
>      non-exposed mothers. In addition, the children
> of DES mothers
>      showed a high incidence of reproductive
> abnormalities,
>      miscarriages, vaginal cancer, testicular
> cancer, sterility and
>      immune dysfunction. In fact, it is feared that
> repercussions of
>      this drug will be felt for generations to come.
>      The irony of this entire debacle is that the
> medical establishment
>      finally acknowledged that DES was useless in
> preventing
>      miscarriages. Thus, DES, another disastrous
> experiment on women,
>      was added to the long list of major medical
> blunders.
>      Out of this early research, a new drug appeared
> on the horizon
>      which would be soon be heralded as a shining
> star in the war
>      against the growing epidemic of breast cancer.
> In the late 1960's
>      the pharmaceutical industry developed a drug
> called "tamoxifen".
>      As a synthetic, non-steroidal compound with
> hormone-like effects
>      (many of which are poorly understood),
> tamoxifen has a similar
>      structure to DES. In fact, it was observed that
> tamoxifen caused
>      the same abnormal changes seen in cells of
> women taking estradiol
>      and DES. (1) This similarity raised alarm bells
> for some.
>      Pierre Blais, well known as a drug researcher
> who was ejected from
>      Canada's health protection bureaucracy when he
> spoke out about
>      silicone breast implants, describes the story
> of tamoxifen as "the
>      story of modern drug design which produces
> garbage drugs". He
>      says, "Good drug design ceased, unfortunately,
> in the 1930s."
>      Tamoxifen, Blais asserts, " a garbage drug
> that made it to
>      the top of the scrap heap. It is a DES in the
> making." (2)
=== message truncated ===

Do You Yahoo!?
Kick off your party with Yahoo! Invites.
This is an automatically-generated notice.  If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <>, or send an email message to:
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email